Busulfan — chemotherapy before transplant and in blood disorders

What busulfan is in simple patient language

Busulfan is a drug that hits cells which divide fast. The bone marrow takes the strongest hit. That is the point of it.

Most of the time, doctors bring it up not as a regular chemo course but as a step before a bone marrow or stem cell procedure. The idea is to clear out the old cells and get the disease under control before the next phase of treatment.

The diagnosis alone does not decide whether busulfan is the right choice. The patient’s age, how the liver is working, the current blood picture, infection risk, and what comes after the drug — all of that shapes the decision.

How busulfan works

Busulfan attaches to the DNA of dividing cells and blocks their ability to keep multiplying. The bone marrow reacts strongly to this.

White blood cells, platelets, and red cell counts will fall. The doctor builds the monitoring plan around that. The goal is to catch any problem early, before it turns into something harder to manage.

In most transplant plans, busulfan does not go in alone. It runs alongside other drugs. Not to make things more aggressive, but to prepare the body properly for what comes next.

Which conditions may be treated with busulfan

Busulfan shows up most often in blood cancer care, especially when a transplant is part of the plan. It may be discussed when the patient has:

• leukemia or another blood disorder where a transplant is being planned
• certain conditions where bone marrow activity needs to be reduced before the next step
• a myelodysplastic or related situation that fits a transplant-based approach
• a clinical picture where the doctor needs to choose between different preparative regimens

Having one of these diagnoses does not mean busulfan will be prescribed. For one patient it may be the right fit. For another, a different approach will make more sense given the risks.

When busulfan can be especially relevant

Busulfan tends to come into the conversation when standard treatment is no longer enough and the doctor is thinking about a transplant. It may be particularly relevant when:

• the transplant date is approaching and the body needs to be prepared
• the blood disorder is active and requires stronger control before the procedure
• the doctor is comparing different preparative options for this specific patient
• there is a question about whether the patient can carry an intensive regimen safely
• a previous treatment did not work and the plan needs to be reassessed

The question is not whether busulfan can be given. It is whether this preparation makes sense for this person right now.

What should be checked before treatment

Before busulfan starts, the doctor needs more than a diagnosis. A real clinical picture is required, especially when the drug is part of a transplant plan.

• exact diagnosis and bone marrow findings
• the goal of treatment at this stage
• blood counts and how they have been moving over time
• liver and kidney function
• current infection status and overall infection risk
• what treatments have already been given and how the patient tolerated them
• heart and lung condition
• the plan for supportive care during and after treatment

Liver function carries particular weight with busulfan. Some centres also measure drug levels in the blood during treatment. This helps match the dose more precisely to the individual rather than relying on a general estimate.

How treatment with busulfan is usually given

Busulfan can be given in tablet form or by infusion into a vein. In most current transplant centres, intravenous delivery is more common. The exact schedule depends on the diagnosis, the patient’s weight and organ function, and the protocol the centre uses.

Monitoring during treatment is close. This is not a drug that is given and then checked on weeks later.

• blood counts are reviewed regularly
• liver markers are followed throughout the course
• the mouth, gut, and skin are assessed for reactions
• infection prevention follows the centre’s protocol
• some patients receive medication to lower the risk of seizures
• drug levels in the blood are measured when the centre uses that approach
• supportive treatment is adjusted based on how the patient is doing

A drop in blood counts during this treatment is expected. The risk comes when a fever, bleed, or liver symptom appears at home and the patient tries to wait it out. That is when delays become dangerous.

Possible side effects

Busulfan affects the bone marrow deeply. That is what makes it useful and what makes it serious at the same time. Close follow-up is not optional here.

• significant drop in white blood cells, platelets, and hemoglobin
• infections while the immune system is suppressed
• bleeding or bruising when platelet counts are low
• nausea, vomiting, and reduced appetite
• sores or inflammation inside the mouth
• diarrhea or stomach pain
• tiredness and general physical weakness
• changes in liver test results
• skin darkening in some patients
• seizure risk with certain dosing schedules
• rare but serious liver or lung complications

Some of these effects are expected and already factored into the monitoring plan. Expected does not mean they can be ignored. Reporting early is what keeps a manageable problem from becoming a reason to stop treatment.

When to contact a doctor urgently

During busulfan treatment, do not wait for the next scheduled appointment if any of the following appear:

• fever or chills
• bleeding from any site, or blood in urine or stool
• new bruising or small red spots appearing on the skin
• severe tiredness, dizziness, or passing out
• mouth pain bad enough to make drinking difficult
• vomiting or diarrhea that is getting worse
• yellowing of the skin or eyes
• pain or a heavy feeling on the right side below the ribs
• difficulty breathing, cough, or chest pain
• confusion, shaking, or any unusual neurological symptom

Not every symptom will turn out to be serious. But with busulfan, checking early is always the right call. Fever, bleeding, liver signs, and any new neurological change need prompt attention.

Why busulfan is not right for every patient

Busulfan is a powerful drug, and that is exactly why it does not suit every patient. Several things affect whether it is a safe option:

• whether a transplant is planned and what the treatment goal is
• the patient’s age and general physical condition
• how well the liver is functioning
• current infection risk
• the state of the bone marrow before treatment begins
• what therapy has already been given
• other medical conditions the patient has
• access to the kind of close monitoring this drug requires

When the doctor chooses a different preparative regimen, it is not because busulfan is the wrong drug in general. It is because for this particular person at this moment, the risk is too high. That is a normal part of planning in blood cancer care.

Can busulfan be combined with other treatments

Yes. Busulfan is rarely used alone. In transplant preparation it is almost always part of a combination. Common pairings include:

• fludarabine
• cyclophosphamide
• melphalan
• other drugs based on the centre’s protocol
• supportive medications to manage infections and other complications

Any combination needs a clear reason. When the regimen is intensive, the doctor looks at both the anti-disease rationale and what the patient’s liver, blood counts, and overall condition can realistically carry.

What no quick response can mean

With busulfan, there is often no obvious moment where you can say it worked or it did not. This is especially true when it is used before a transplant.

The purpose here is different from a standard chemo course. The goal is to prepare the marrow, reduce disease activity, and create the right conditions for new cells to take hold. Results play out over weeks, not days.

The doctor watches blood recovery, infection patterns, liver function, marrow data, and how the new cells settle in. These are read together over time. A difficult first week is not a verdict on the whole plan.

Oncology consultation in Israel

At Tel Aviv Medical Clinic, patients can discuss whether busulfan fits their situation. This is most useful when transplant preparation is being planned or when the choice of regimen is not straightforward.

A consultation may help when:

• it is not clear why busulfan was proposed in the treatment plan
• different preparative regimens need to be compared
• liver function, blood counts, and infection risk need specialist review
• bone marrow results and recent labs need to be discussed in context
• a second opinion is needed before an intensive phase of treatment
• the patient needs help preparing questions for the treating hematologist

We do not prescribe treatment remotely. We help the patient and family understand what is being proposed and why, so they can move into the next conversation with their doctor better prepared.

Frequently asked questions — answered by Dr. Stefanska and Dr. Meerovich

1. Does busulfan always mean a transplant is next?

Busulfan shows up in transplant plans very often, but that is not the only situation. I ask the family to tell me exactly what the doctor wrote in the plan. The purpose matters more than the drug name. Conditioning before a procedure, slowing down an active disease, or a combined approach — each of these leads to a different conversation about what the patient should expect.

2. Why does the doctor need so many results before starting?

This drug works hard on the marrow and on the liver. A patient can have the right diagnosis and still not be ready for busulfan. Liver numbers, platelet and neutrophil levels, any signs of ongoing infection — these are not background details. They decide whether starting right now is reasonable or whether waiting makes more sense. I have seen plans change based on a single lab result.

3. Can another drug be used instead?

There is no universal answer. Some regimens can be adjusted. Others cannot, because the drug choice is tied to the type of disease and the specific transplant centre protocol. When a switch is proposed, I want to understand the actual reason. Age, organ function, prior therapy, or the centre’s own experience — the reason reveals whether the change is a safety call or just a preference.

4. Why do some patients have their drug levels measured during treatment?

Bodies absorb and clear busulfan at different rates. Two patients on the same dose can end up with very different amounts of the drug actually active in their system. When the centre tracks this, it can make small corrections in real time. The result is a plan that fits the individual rather than a standard weight-based estimate. Not all centres do this, but it is a meaningful tool where it is available.

5. Which symptoms should be reported right away?

Call right away if the patient develops a fever, notices any unusual bleeding, sees the skin or eyes go yellow, feels pain on the right side of the abdomen, has trouble breathing, or experiences sudden confusion. These are not things to monitor at home and report at the next visit. During this treatment, delays in getting help can turn a manageable problem into something far harder to treat.

6. Is busulfan harder on the body than other chemo drugs?

The harder or easier question does not quite apply here. Busulfan is used at a specific point in a specific plan. Before a transplant, it is not a standalone chemo course. It is the bridge between where the patient is now and where the transplant needs them to be. The support and monitoring around it have to reflect that. It is a different kind of treatment burden, not simply a bigger one.

7. What documents are useful to bring to a consultation?

The most useful things to have ready: the paper showing the current diagnosis, the bone marrow result, blood tests from the last few weeks, liver and kidney values, and a simple list of every treatment the patient has already received. If a transplant plan exists in writing, bring that too. A short handwritten summary of how the disease has developed over time is often more helpful than a stack of unsorted papers.

Important information

This page contains general medical information only. It is not a treatment recommendation. Busulfan is considered only after a full review of the diagnosis, treatment goal, bone marrow status, liver function, and the patient’s overall condition.

Do not start, stop, or change any treatment without speaking to your treating physician first.

For a consultation about busulfan:

📞 +972-73-374-6844

📧 [email protected]

💬 WhatsApp: +972-52-337-3108